The drug-store chain on Thursday raised its full-year adjusted earnings outlook to low-single-digit growth from flat following a fiscal first quarter that crushed Wall Street analysts’ expectations. The shares fell 1.4% at 11:19 a.m. in New York.
Covid vaccines and tests propelled Walgreens’s quarterly beat, but its forecast implies a lower profit than Wall Street expects, Raymond James analyst
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.